Details of the Drug Reposition

General Information of This Drug (ID: DM4NMBW)

Drug Name	Anti-Mesothelin CAR-T cells DM4NMBW
Drug Type	CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

3 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Gastric adenocarcinoma	DISWWLTC	2B72	Phase 1/2	[1]
Pancreatic cancer	DISJC981	2C10	Phase 1/2	[1]
Mesothelioma	DISKWK9M	2C51.2	Phase 1/2	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT03638206) Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies